{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:07Z","timestamp":1791388987132,"version":"4.3.3"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T00:00:00Z","timestamp":1336953600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0036743","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T21:32:07Z","timestamp":1337031127000},"page":"e36743","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":83,"title":["Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats"],"prefix":"10.1371","volume":"7","author":[{"given":"K. Yaragudri","family":"Vinod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Psychoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basalingappa L.","family":"Hungund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanaz M.","family":"Tejani-Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"ref1","article-title":"(American Psychiatric Association, Washington, DC)","author":"Diagnostic","year":"2004"},{"key":"ref2","article-title":"World Health Organization website.","volume":"15"},{"key":"ref3","article-title":"<italic>Reducing Suicide: A National Imperative<\/italic>.","year":"2002"},{"key":"ref4","first-page":"5","article-title":"Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond.","volume":"65","author":"MJ Owens","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.tips.2006.08.006","article-title":"Role of the endocannabinoid system in depression and suicide.","volume":"27","author":"KY Vinod","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/sj.mp.4001376","article-title":"Upregulation of CB1 receptors and agonist-stimulated [<sup>35<\/sup>S]GTP\u03b3S binding in the prefrontal cortex of depressed suicide victims.","volume":"9","author":"BL Hungund","year":"2004","journal-title":"Mol Psychiatry"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.","volume":"102","author":"G Gobbi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00008877-200509000-00006","article-title":"Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?","volume":"16","author":"MN Hill","year":"2005","journal-title":"Behav Pharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.","volume":"27","author":"FR Bambico","year":"2007","journal-title":"J Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.","volume":"62","author":"M Bortolato","year":"2007","journal-title":"Biol Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00008877-200312000-00001","article-title":"Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice.","volume":"14","author":"LP Shearman","year":"2003","journal-title":"Behav Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2004.10.032","article-title":": Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.","volume":"57","author":"G Griebel","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","article-title":"The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.","volume":"138","author":"ET Tzavara","year":"2003","journal-title":"Br J Pharmacol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tips.2005.10.006","article-title":"A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.","volume":"26","author":"JM Witkin","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"ref15","article-title":"Chapter: <italic>Depression: Behavior and Brain: Insights from an Animal Model.<\/italic>","author":"W Pare","year":"2003"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neuropharm.2011.02.017","article-title":"Modeling treatment-resistant depression.","volume":"61","author":"BA Samuels","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-8993(94)91045-6","article-title":"Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats.","volume":"649","author":"SM Tejani-Butt","year":"1994","journal-title":"Brain Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1038\/sj.npp.1301100","article-title":"Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats.","volume":"31","author":"KA Pearson","year":"2006","journal-title":"Neuropsychopharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.mp.4001345","article-title":"Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants.","volume":"8","author":"CC Will","year":"2003","journal-title":"Mol Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brainres.2004.06.052","article-title":"A distinct neurochemical profile in WKY rats at baseline and in response toacute stress: implications for animal models of anxiety and depression.","volume":"1021","author":"De La Garza R 2nd","year":"2004","journal-title":"Brain Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopsych.2005.05.039","article-title":"Two different putative genetic animal models of childhood depression.","volume":"59","author":"O Malkesman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nn1971","article-title":"New insights into BDNF function in depression and anxiety.","volume":"10","author":"K Martinowich","year":"2007","journal-title":"Nat Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.biopsych.2004.11.033","article-title":"Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims.","volume":"57","author":"KY Vinod","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jpsychires.2009.11.013","article-title":"Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides.","volume":"44","author":"KY Vinod","year":"2010","journal-title":"J Psychiatric Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0306-4530(01)00052-X","article-title":"Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat.","volume":"27","author":"PA Rittenhouse","year":"2002","journal-title":"Psychoneuroendocrinol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1460-9568.2006.05061.x","article-title":"Endocannabinoids modulate stress-induced suppression of hippocampal cell proliferation and activation of defensive behaviours.","volume":"24","author":"MN Hill","year":"2006","journal-title":"Eur J Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.phrs.2007.09.003","article-title":"Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.","volume":"56","author":"RA Mangieri","year":"2007","journal-title":"Pharmacol Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/j.1471-4159.2008.05567.x","article-title":"Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.","volume":"106","author":"MN Hill","year":"2008","journal-title":"J Neurochem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2011.04.031","article-title":"Involvement of endocannabinoids in antidepressant and anti-compulsive effect of fluoxetine in mice.","volume":"223","author":"SN Umathe","year":"2011","journal-title":"Behav Brain Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/npp.2009.114","article-title":"Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.","volume":"34","author":"MN Hill","year":"2009","journal-title":"Neuropsychopharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pbb.2010.12.002","article-title":"Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.","volume":"98","author":"SG Kinsey","year":"2011","journal-title":"32Pharmacol Biochem Behav"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1124\/mol.110.064196","article-title":"Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition.","volume":"78","author":"S Rossi","year":"2010","journal-title":"Mol Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.phrs.2010.01.002","article-title":"Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.","volume":"61","author":"P Monteleone","year":"2010","journal-title":"Pharmacol Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2174\/156800705774933023","article-title":"Endocannabinoids in neuroimmunology and stress.","volume":"4","author":"EJ Carrier","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FBP.0b013e3282ee7b44","article-title":"Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.","volume":"18","author":"RJ McLaughlin","year":"2007","journal-title":"Behav Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1176\/appi.ajp.160.8.1516","article-title":"Untreated depression and hippocampal volume loss.","volume":"160","author":"MH Sheline Gado","year":"2003","journal-title":"Am J Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0166-2236(96)10069-2","article-title":"Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis.","volume":"20","author":"JP Herman","year":"1997","journal-title":"Trends Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","article-title":"Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.","volume":"57","author":"RM Sapolsky","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1749-6632.2001.tb05830.x","article-title":"Plasticity of the hippocampus: adaptation to chronic stress and allostatic load.","volume":"933","author":"BS McEwen","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.162.6.1057","article-title":"Depression and the Hippocampus.","volume":"162","author":"A Neumeister","year":"2005","journal-title":"Am J Psychiatry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.","volume":"8","author":"L Santarelli","year":"2003","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1381612053382223","article-title":"Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.","volume":"11","author":"JE Malberg","year":"2005","journal-title":"Curr Pharm Des"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/WNR.0b013e328273bcb0","article-title":": The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.","volume":"18","author":"L Ribeiro","year":"2007","journal-title":"Neuroreport"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2147\/NDT.S5700","article-title":"\u201cBrain-derived neurotrophic factor: role in depression and suicide\u201d.","volume":"5","author":"Y Dwivedi","year":"2009","journal-title":"Neuropsychiatric Dis Treat"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1471-4159.2009.06345.x","article-title":"Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression.","volume":"111","author":"B Haenisch","year":"2009","journal-title":"J Neurochem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0306-4522(00)00349-3","article-title":"\u201cPhysical activity, and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus\u201d.","volume":"101","author":"AA Russo-Neustadt","year":"2000","journal-title":"Neuroscience"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0006-3223(03)00181-1","article-title":"\u201cAlterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants\u201d.","volume":"54","author":"E Shimizu","year":"2003","journal-title":"Biol Psychiatry"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.pnpbp.2008.02.009","article-title":"\u201cEfficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study\u201d.","volume":"32","author":"T Okamoto","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref49","first-page":"160","article-title":"\u201cElectroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy\u201d. The Journal of ECT.","volume":"24","author":"SM Taylor","year":"2008"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0074-7742(06)73005-7","article-title":"Effects of genes and stress on the neurobiology of depression.","volume":"73","author":"JJ Mann","year":"2006","journal-title":"Int Rev Neurobiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00124509-199903000-00004","article-title":"EEG correlates of the response to ECT: a possible antidepressant role of brain-derived neurotrophic factor.","volume":"15","author":"AD Krystal","year":"1999","journal-title":"J ECT"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders.","volume":"59","author":"RS Duman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1471-4159.2007.05149.x","article-title":"BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice.","volume":"105","author":"E Aso","year":"2008","journal-title":"J Neurochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1172\/JCI25509","article-title":"Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects.","volume":"115","author":"W Jiang","year":"2005","journal-title":"J Clin Invest"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S1461145709000030","article-title":"Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response.","volume":"13","author":"K Domschke","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.psychres.2010.04.013","article-title":"Cyclic-AMP response element binding protein (CREB) in the neutrophils of depressed patients.","volume":"185","author":"X Ren","year":"2011","journal-title":"Psychiatry Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/WNR.0b013e328321b5a0","article-title":"Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus.","volume":"18","author":"GW Reierson","year":"2009","journal-title":"Neuroreport"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.phrs.2010.01.002","article-title":"Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.","volume":"61","author":"P Monteleone","year":"2010","journal-title":"Pharmacol Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.euroneuro.2008.05.003","article-title":"Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.","volume":"18","author":"K Domschke","year":"2008","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0036743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T18:22:58Z","timestamp":1561746178000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0036743"}},"subtitle":[],"editor":[{"given":"Silvana","family":"Gaetani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0036743","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}